Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: There were no sales of equity securities during the thirteen weeks ended March 26, 2023 that were not registered under the Securities Act.
−Removed: The following table provides information regarding our purchases of common stock during the thirteen weeks ended March 26, 2023:
+Added: Conversion of 2025 Notes - During the thirteen weeks ended June 25, 2023, certain holders of our 2025 Notes elected to convert $0.2 million in aggregate principal amount of 2025 Notes for a combination of an aggregate of $0.2 million in cash and 9,925 shares of our common stock.
+Added: The shares of common stock issued upon conversion of the 2025 Notes were issued in reliance upon the exemptions from the registration requirements of the Securities Act provided by Sections 3(a)(9) and 4(a)(2) thereof.
+Added: In connection with the conversion of the 2025 Notes, we exercised our rights under certain convertible note hedge transactions during the thirteen weeks ended June 25, 2023 and received a proportionate amount of our common stock.
+Added: There were no other sales of equity securities during the thirteen weeks ended June 25, 2023 that were not registered under the Securities Act.
+Added: Share Repurchases - The following table provides information regarding our purchases of common stock during the thirteen weeks ended June 25, 2023:
REPORTING PERIOD TOTAL NUMBER OF SHARES PURCHASED AVERAGE PRICE PAID PER SHARE TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PLANS OR PROGRAMS APPROXIMATE DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PLANS OR PROGRAMS (1)
−Removed: December 26, 2022 through January 22, 2023 314,175 $ 21.97 314,175 $ 8,099,645
−Removed: January 23, 2023 through February 19, 2023 330,114 $ 24.53 330,114 $ 125,000,664
−Removed: February 20, 2023 through March 26, 2023 218,688 $ 25.81 218,688 $ 119,355,724
+Added: March 27, 2023 through April 23, 2023 227,812 $ 24.96 227,812 $ 113,669,958
+Added: April 24, 2023 through May 21, 2023 124,149 $ 24.10 124,149 $ 110,677,940
+Added: May 22, 2023 through June 25, 2023 266,752 $ 25.72 266,752 $ 103,817,009
Total 618,713 618,713
____________________
−Removed: (1) On February 8, 2022, our Board of Directors authorized the repurchase of up to $125.0 million of our outstanding common stock as announced in our press release issued on February 18, 2022 (the “2022 Share Repurchase Program”).
−Removed: The 2022 Share Repurchase Program was set to expire on August 9, 2023.
−Removed: During the thirteen weeks ended March 26, 2023, we fully utilized the remaining share repurchase authorization under the 2022 Share Repurchase Program.
−Removed: On February 7, 2023, our Board approved a new share repurchase authorization of up to $125.0 million of our outstanding common stock as announced in our press release issued February 16, 2023 (the “2023 Share Repurchase Program”).
+Added: (1) On February 7, 2023, our Board approved a share repurchase authorization of up to $125.0 million of our outstanding common stock as announced in our press release issued February 16, 2023 (the “2023 Share Repurchase Program”).
The 2023 Share Repurchase Program will expire on August 7, 2024.
6 unchanged sentences
April 19, 2023, Form 8-K, Exhibit 3.2
−Removed: 4.1 Description of Common Stock
−Removed: Filed herewith
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
19 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: May 2, 2023 BLOOMIN’ BRANDS, INC.
+Added: August 1, 2023 BLOOMIN’ BRANDS, INC.
/s/ Philip Pace
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.